RE:RE:RE:RE:Roche CD47 antibody start-up gives up-lays off all employeesGreat find Noteable. I always looked towards the Forty Seven acquisition amount as appropriate for Oncy before PDAC & CRC proved out, when we were just the mBC indication. Now Gilead would have to spend in & around triple that $4.9b to get Oncy.